92 related articles for article (PubMed ID: 17149054)
1. Polyarthritis flare complicating rheumatoid arthritis infliximab therapy: a paradoxic adverse reaction.
Rozenbaum M; Boulman N; Slobodin G; Ayubkhanov E; Rosner I
J Clin Rheumatol; 2006 Dec; 12(6):269-71. PubMed ID: 17149054
[TBL] [Abstract][Full Text] [Related]
2. Infliximab treatment in patients with rheumatoid arthritis and spondyloarthropathies in clinical practice: adverse events and other reasons for discontinuation of treatment.
Levälampi T; Korpela M; Vuolteenaho K; Moilanen E
Scand J Rheumatol; 2008; 37(1):6-12. PubMed ID: 18189188
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results.
Braun-Moscovici Y; Markovits D; Rozin A; Toledano K; Nahir AM; Balbir-Gurman A
Isr Med Assoc J; 2008 Apr; 10(4):277-81. PubMed ID: 18548981
[TBL] [Abstract][Full Text] [Related]
4. Sustained effect after lowering high-dose infliximab in patients with rheumatoid arthritis: a prospective dose titration study.
van den Bemt BJ; den Broeder AA; Snijders GF; Hekster YA; van Riel PL; Benraad B; Wolbink GJ; van den Hoogen FH
Ann Rheum Dis; 2008 Dec; 67(12):1697-701. PubMed ID: 18245109
[TBL] [Abstract][Full Text] [Related]
5. [Case report: RAEB in a patient with rheumatoid arthritis treated with methotrexate and infliximab].
D'Alessandro G; Bianco MR; Politis S; Ferrandina C; Rossi G; Altomare E
Reumatismo; 2006; 58(1):59-61. PubMed ID: 16639489
[TBL] [Abstract][Full Text] [Related]
6. Rapid and deep control of inflammation in rheumatoid arthritis with infliximab and its correlation with acute-phase reactants.
Scali JJ; Visentini S; Salomón J; Sevilla D; Ju YC; Morales E; Ugarte L; Tachdjian A; Pacheco G; Veiga S
Ann N Y Acad Sci; 2007 Sep; 1110():389-401. PubMed ID: 17911454
[TBL] [Abstract][Full Text] [Related]
7. Treatment with infliximab plus methotrexate improves anemia in patients with rheumatoid arthritis independent of improvement in other clinical outcome measures-a pooled analysis from three large, multicenter, double-blind, randomized clinical trials.
Doyle MK; Rahman MU; Han C; Han J; Giles J; Bingham CO; Bathon J
Semin Arthritis Rheum; 2009 Oct; 39(2):123-31. PubMed ID: 18823645
[TBL] [Abstract][Full Text] [Related]
8. Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone.
Durez P; Malghem J; Nzeusseu Toukap A; Depresseux G; Lauwerys BR; Westhovens R; Luyten FP; Corluy L; Houssiau FA; Verschueren P
Arthritis Rheum; 2007 Dec; 56(12):3919-27. PubMed ID: 18050189
[TBL] [Abstract][Full Text] [Related]
9. Dose intensification with infliximab in patients with rheumatoid arthritis.
Berger A; Edelsberg J; Li TT; Maclean JR; Oster G
Ann Pharmacother; 2005 Dec; 39(12):2021-5. PubMed ID: 16288073
[TBL] [Abstract][Full Text] [Related]
10. Response to pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone.
Visvanathan S; Keenan GF; Baker DG; Levinson AI; Wagner CL
J Rheumatol; 2007 May; 34(5):952-7. PubMed ID: 17444589
[TBL] [Abstract][Full Text] [Related]
11. Predictors of infusion reactions during infliximab treatment in patients with arthritis.
Kapetanovic MC; Larsson L; Truedsson L; Sturfelt G; Saxne T; Geborek P
Arthritis Res Ther; 2006; 8(4):R131. PubMed ID: 16869978
[TBL] [Abstract][Full Text] [Related]
12. Long-term infliximab treatment in rheumatoid arthritis: subsequent outcome of initial responders.
Buch MH; Bingham SJ; Bryer D; Emery P
Rheumatology (Oxford); 2007 Jul; 46(7):1153-6. PubMed ID: 17478470
[TBL] [Abstract][Full Text] [Related]
13. Impact of treatment with infliximab on serum cytokine profile of patients with rheumatoid and psoriatic arthritis.
Amital H; Barak V; Winkler RE; Rubinow A
Ann N Y Acad Sci; 2007 Sep; 1110():649-60. PubMed ID: 17911480
[TBL] [Abstract][Full Text] [Related]
14. Overcoming drug resistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis.
Tsujimura S; Saito K; Nawata M; Nakayamada S; Tanaka Y
Ann Rheum Dis; 2008 Mar; 67(3):380-8. PubMed ID: 17660216
[TBL] [Abstract][Full Text] [Related]
15. Therapy of patients with rheumatoid arthritis: outcome of infliximab failures switched to etanercept.
Buch MH; Bingham SJ; Bejarano V; Bryer D; White J; Reece R; Quinn M; Emery P
Arthritis Rheum; 2007 Apr; 57(3):448-53. PubMed ID: 17394231
[TBL] [Abstract][Full Text] [Related]
16. Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy.
Wolfe F; Michaud K; Anderson J; Urbansky K
Arthritis Rheum; 2004 Feb; 50(2):372-9. PubMed ID: 14872478
[TBL] [Abstract][Full Text] [Related]
17. Infliximab improves vascular stiffness in patients with rheumatoid arthritis.
Wong M; Oakley SP; Young L; Jiang BY; Wierzbicki A; Panayi G; Chowienczyk P; Kirkham B
Ann Rheum Dis; 2009 Aug; 68(8):1277-84. PubMed ID: 18930987
[TBL] [Abstract][Full Text] [Related]
18. Infliximab but not methotrexate induces extra-high levels of VLDL-triglyceride in patients with rheumatoid arthritis.
Saiki O; Takao R; Naruse Y; Kuhara M; Imai S; Uda H
J Rheumatol; 2007 Oct; 34(10):1997-2004. PubMed ID: 17787045
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary complications of infliximab therapy in patients with rheumatoid arthritis.
Ostör AJ; Chilvers ER; Somerville MF; Lim AY; Lane SE; Crisp AJ; Scott DG
J Rheumatol; 2006 Mar; 33(3):622-8. PubMed ID: 16511933
[TBL] [Abstract][Full Text] [Related]
20. Increased tumor necrosis factor-alpha mRNA expression in whole blood from patients with rheumatoid arthritis: reduction after infliximab treatment does not predict response.
Pachot A; Arnaud B; Marrote H; Cazalis MA; Diasparra J; Gouraud A; Mougin B; Miossec P
J Rheumatol; 2007 Nov; 34(11):2158-61. PubMed ID: 17896807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]